首页> 中文期刊> 《中国药房》 >5-氟尿嘧啶致中性粒细胞减少伴发热及化疗相关性腹泻的药学监护

5-氟尿嘧啶致中性粒细胞减少伴发热及化疗相关性腹泻的药学监护

         

摘要

目的:探讨临床药师在抗肿瘤药不良反应(ADR)处理方面如何具体提供恰当的药学监护。方法:针对1例5-氟尿嘧啶(5-FU)化疗引起中性粒细胞减少伴发热及化疗相关性腹泻的患者,临床药师在治疗中建议医师依次使用亚胺培南/西司他丁0.5 g, q6 h,ivgtt→去甲万古霉素0.4 g,q6 h,po→左氧氟沙星0.4 g,qd,ivgtt等抗菌药物治疗,及使用洛哌丁胺首剂4 mg,随后2 mg,q4 h止泻。结果:经过恰当的抗菌药物及止泻药物治疗22 d后,患者的体温、血象恢复正常,腹泻停止,血人绒毛膜促性腺激素(β-HCG)下降至61.58 U/L,予以出院。结论:临床药师协助医师优化治疗方案并实施药学监护,有利于优化化疗药物治疗方案及ADR的处理,保障患者治疗安全。%OBJECTIVE:To investigate the way to provide suitable pharmacecaical care for antineophastic drug-induced ADR by clinical pharmacists. METHODS:For one case of 5-FU chemotherapy-induced neutropenia associated with fever and diarrhea, clinical pharmacists provided advices on antibacterial treatment,including imipenem/cilastatin 0.5 g,q6 h,ivgtt;norvancomycin 0.4 g,q6 h,po;levofloxacin 0.4 g,qd,ivgtt;loperamide with initial dose of 4 mg for anti-diarrheal medication,maintaining at 2 mg,q4 h. RESULTS:After 22 days of appropriate antibacterial and anti-diarrheal treatment,the patient's body temperature and he-mogram returned to normal,diarrhea stopped and β-HCG decreased to 61.58 U/L;then the patient was discharged from hospital. CONCLUSIONS:It is beneficial to optimize chemotherapy plan and ADR disposal,and ensure the safety of the treatment that clini-cal pharmacists assist physicans to optimize therapy plan and provide pharmaceutical care.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号